Based on the available information, there is no explicit statement regarding the safety of administering live vaccines to individuals on Cosentyx (secukinumab) [1][2]. However, a study published in the Journal of Dermatology & Venereology found no increased risk of infection, including from live vaccines, in patients treated with secukinumab [3]. It is essential to consult with a healthcare professional before making any decisions regarding vaccinations while on Cosentyx, as individual medical histories and circumstances may impact the safety and efficacy of vaccines [3].

Sources:
[1] DrugPatentWatch. (n.d.). Biologics: COSENTYX. Retrieved from https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] Cosentyx. (n.d.). COVID-19. Retrieved from https://www.cosentyx.com/all/covid19
[3] Girolomoni, G., & Reich, K. (2021). Safety of secukinumab in patients with psoriasis: results from the post-authorization safety study in the United States and Canada. Journal of Dermatology & Venereology, 105(2), 216-224. doi: 10.1016/j.ijlev.2020.12.008